Manufacturers Life Insurance Company, The Edgewise Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 40,170 shares of EWTX stock, worth $934,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,170
Previous 38,410
4.58%
Holding current value
$934,755
Previous $1.03 Million
4.59%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding EWTX
# of Institutions
216Shares Held
98.2MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$350 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$207 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$143 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$140 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$116 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.47B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...